Currently, the United States and New Zealand are the only two countries in the world that allow such advertisements. But ...
Conservative media outlets like Fox News and The Daily Wire say they're experiencing a surge in advertising demand.
Drugs from Novartis, Amgen and now Lilly have proven powerfully effective at reducing Lp(a). Whether that will translate to a ...
Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are ...
5h
Zacks Investment Research on MSNIs the Future Bleak for SAVA Stock Following Another Setback?Cassava Sciences SAVA recently suffered yet another setback, which raises concern regarding its prospects. Last week, the company announced that the phase III study REFOCUS-ALZ on lead pipeline ...
Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug Administration's top vaccine ...
FBN Securities began coverage on shares of AppLovin (NASDAQ:APP – Free Report) in a research report sent to investors on Friday, MarketBeat.com reports. The firm issued an outperform rating and a $385 ...
Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...
There was almost no criticism of the trade that disregarded Davis' talent as a player. ESPN's Kevin Pelton graded the ...
JP Morgan sees strong growth for Ascentage Pharma, citing its late-stage cancer drugs. The biotech's 2024 sales surged 342% ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Proprietary listener insights that demonstrate why streaming audio should be an integral part of a pharma marketer’s media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results